The Journal of Practical Medicine >
Effect of citicoline sodium combined with Eurekline on the expression of miR⁃17⁃5p and miR⁃29b in patients with ischemic stroke
Received date: 2024-03-27
Online published: 2024-10-22
Objective To investigate the effects of citicoline sodium and Ureicrin on the expression of miR-17-5p and miR-29b in patients with ischemic stroke. Methods A total of 100 patients with ischemic stroke treated in the hospital were divided into control group and combination group by random table method. From February 2023 to February 2024， they were respectively given Eurecrine monotherapy and citicoline sodium and eurecrine combination therapy. Cerebral blood perfusion indexes， inflammatory factors， oxidative stress， miR-17-5p， miR-29b levels and clinical efficacy were detected in the two groups， and adverse reactions were statistically recorded. Results There was no significant difference in CBF， CBV， hs-CRP， miR-29b， IL-6， TNF-α and miR-17-5p between the two groups before treatment （P > 0.05）. After treatment， the levels of CBF， CBV， miR-29b， SOD and GSH-Px increased， while the levels of hs-CRP， IL-6， TNF-α， miR-17-5p and MDA decreased， and the levels of CBF， CBV， miR-29b， SOD and GSH-Px in the combined group were higher than those in the control group. The levels of hs-CRP， TNF-α， IL-6， miR-17-5p and MDA were significantly different from those of the control group （P < 0.05）. The incidence of adverse reactions and the total effective rate of treatment in combination group were higher than those in control group （P < 0.05）， and the adverse reactions were mild and tolerable. Conclusion The combination of citicoline sodium and Ureicrin can improve the clinical efficacy and prognosis of patients.
Key words： citicoline sodium; eurekline; ischemic stroke; miR-17-5p; miR-29b
Baozhu ZHAO , Zhengming DU , Xiuxiu. CHEN . Effect of citicoline sodium combined with Eurekline on the expression of miR⁃17⁃5p and miR⁃29b in patients with ischemic stroke[J]. The Journal of Practical Medicine, 2024 , 40(19) : 2733 -2737 . DOI: 10.3969/j.issn.1006-5725.2024.19.012
| 1 | TIEDT S， BRANDMAIER S， KOLLMEIER H， et al. Circulating metabolites differentiate acute ischemic stroke from stroke mimics［J］. Ann Neurol，2020，88（4）：736-746. doi:10.1002/ana.25859 |
| 2 | 郭飞，黄云慧，黄宇靖，等. 醒脑静注射液联合阿替普酶治疗缺血性脑卒中疗效和安全性的系统评价［J］. 实用医学杂志，2022，38（2）：206-211. doi:10.3969/j.issn.1006?5725.2022.02.015 |
| 3 | BEUTER A， BALOSSIER A， VASSAL F， et al. Cortical stimulation in aphasia following ischemic stroke： Toward model-guided electrical neuromodulation［J］. Biol Cybern，2020，114（1）：5-21. doi:10.1007/s00422-020-00818-w |
| 4 | 张雪婷，韩新源，王暄齐，等. 曲克芦丁联合高频电疗法对缺血性脑卒中患者血清中miR?137及miR?155表达的影响［J］. 实用医学杂志，2022，38（12）：1517-1521. |
| 5 | WANG Q， HU M， YE P. Effect of a modern stroke unit combined with recombinant human tissue-type plasminogen activator intravenous thrombolysis on ischemic cerebral infarction and its influence on limb motor function and activity of daily living［J］. Am J Transl Res，2021，13（8）：9708-9714. |
| 6 | PAN Q， WANG Y， LIU J， et al. MiR-17-5p mediates the effects of ACE2-enriched endothelial progenitor cell-derived exosomes on ameliorating cerebral ischemic injury in aged mice［J］. Mol Neurobiol，2023，60（6）：3534-3552. doi:10.1007/s12035-023-03280-4 |
| 7 | MA Y H， DENG W J， LUO Z Y， et al. Inhibition of microRNA-29b suppresses oxidative stress and reduces apoptosis in ischemic stroke［J］. Neural Regen Res，2022，17（2）：433-439. doi:10.4103/1673-5374.314319 |
| 8 | 中华医学会神经病学分会， 中华医学会神经病学分会脑血管病学组. 中国急性脑梗死后出血转化诊治共识2019［J］. 中华神经科杂志， 2019， 52（4）： 252-265. |
| 9 | BENZ A P， HOHNLOSER S H， EIKELBOOM J W， et al. Outcomes of patients with atrial fibrillation and ischemic stroke while on oral anticoagulation［J］. Eur Heart J，2023，44（20）：1807-1814. doi:10.1093/eurheartj/ehad200 |
| 10 | PLOTNIKOV M B， CHERNYSHEVA G A， SMOLYAKOVA V I， et al. Neuroprotective effects of a novel inhibitor of c-Jun n-terminal kinase in the rat model of transient focal cerebral ischemia［J］. Cells，2020，9（8）：1860. doi:10.3390/cells9081860 |
| 11 | ALHABEEB W， MRABETI S， ABDELSALAM A A I. Therapeutic properties of highly selective β-blockers with or without additional vasodilator properties： Focus on bisoprolol and nebivolol in patients with cardiovascular disease［J］. Cardiovasc Drugs Ther，2022，36（5）：959-971. doi:10.1007/s10557-021-07205-y |
| 12 | LIU X， CHEN J， LIU G， et al. MicroRNA-17-5p， a novel endothelial cell modulator， controls vascular re-endothelialization and neointimal lesion formation［J］. Vascular，2023，31（2）：392-401. doi:10.1177/17085381211067672 |
| 13 | ZHAN Y， GUO Z， ZHENG F， et al. Reactive oxygen species regulate miR-17-5p expression via DNA methylation in paraquat-induced nerve cell damage［J］. Environ Toxicol，2020，35（12）：1364-1373. doi:10.1002/tox.23001 |
| 14 | MIZOHATA Y， TODA H， KOGA M， et al. Neural extracellular vesicle-derived miR-17 in blood as a potential biomarker of subthreshold depression［J］. Hum Cell，2021，34（4）：1087-1092. doi:10.1007/s13577-021-00553-9 |
| 15 | ZHANG L， WANG Z， LI B， et al. The inhibition of miR-17-5p promotes cortical neuron neurite growth via STAT3/GAP-43 pathway［J］. Mol Biol Rep，2020，47（3）：1795-1802. doi:10.1007/s11033-020-05273-1 |
| 16 | WANG Z， CHEN X， LIANG Q， et al. Inhibiting of circ-TLK1 inhibits the progression of glioma through down-regulating PANX1 via targeting miR-17-5p［J］. J Mol Histol，2021，52（5）：1007-1020. doi:10.1007/s10735-021-09993-x |
| 17 | BURLACU C C， CIOBANU D， BADULESCU A V， et al. Circulating microRNAs and extracellular vesicle-derived microRNAs as predictors of functional recovery in ischemic stroke patients： A systematic review and meta-analysis［J］. Int J Mol Sci，2022，24（1）：251. doi:10.3390/ijms24010251 |
| 18 | HOU K， LI G， ZHAO J， et al. Bone mesenchymal stem cell-derived exosomal microRNA-29b-3p prevents hypoxic-ischemic injury in rat brain by activating the PTEN-mediated Akt signaling pathway［J］. J Neuroinflammation，2020，17（1）：46. doi:10.1186/s12974-020-01872-8 |
| 19 | STERNBERG Z， SCHALLER B. Central noradrenergic agonists in the treatment of ischemic stroke-an overview［J］. Transl Stroke Res，2020，11（2）：165-184. doi:10.1007/s12975-019-00718-7 |
| 20 | BACK V， ASGARI A， FRANCZAK A， et al. Inhibition of platelet aggregation by activation of platelet intermediate conductance Ca2+ -activated potassium channels［J］. J Thromb Haemost，2022，20（11）：2587-2600. doi:10.1111/jth.15827 |
| 21 | ZAMOLODCHIKOV D， DUFFIELD M， MACDONALD L E， et al. Accumulation of high molecular weight kininogen in the brains of Alzheimer's disease patients may affect microglial function by altering phagocytosis and lysosomal cathepsin activity［J］. Alzheimers Dement，2022，18（10）：1919-1929. doi:10.1002/alz.12531 |
| 22 | BRAMBILA-TAPIA A J L， JACQUEZ-CASTA?EDA A L， CARRILLO-DELGADILLO L A， et al. Association between psychological， biochemical and personal factors with the inflammatory marker high-sensitive C reactive protein （Hs-CRP） in mexican healthy population［J］. J Pers Med，2023，13（5）：876. doi:10.3390/jpm13050876 |
| 23 | SONG Y， CHEN S， LI L， et al. The hypopigmentation mechanism of tyrosinase inhibitory peptides derived from food proteins： An overview［J］. Molecules，2022，27（9）：2710. doi:10.3390/molecules27092710 |
| 24 | SHI Y， HAN L， ZHANG X， et al. Selenium Alleviates cerebral ischemia/reperfusion injury by regulating oxidative stress， mitochondrial fusion and ferroptosis［J］. Neurochem Res，2022，47（10）：2992-3002. doi:10.1007/s11064-022-03643-8 |
| 25 | DENORME F， PORTIER I， RUSTAD J L， et al. Neutrophil extracellular traps regulate ischemic stroke brain injury［J］. J Clin Invest，2022，132（10）：154225. doi:10.1172/jci154225 |
/
| 〈 |
|
〉 |